Director –Consumer Marketing and B2B Lead, India at Eli Lilly and Company

Gurugram, Haryana, India

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Superlative knowledge of core consumer marketing skills, communication skills, and business acumen
Expert in all aspects of Marketing Go-To-Market (GTM) strategies and Integrated media (Paid, Earned, Owned, Shared)
Ability to conceive and execute integrated strategic marketing rollout plans
Experience driving collaboration and meaningful partnerships with startups, healthcare, and aligned ecosystem industries (e.g., Insurance, FinTech)
Capability to liaise with Lilly leaders in IBU/Global, India Hub across functions like Commercial, Legal, Ethics & Compliance, Corporate Affairs, Medical Affairs, and Procurement
Ability to work closely with Data Sciences & Analytics, Digital Product, and Tech Teams on strategic digitization and automation projects
Understanding of complex Indian market with stringent healthcare regulations and local/global procedures

Responsibilities

Ensure all activities comply with local laws, code, and Lilly procedures
Lead and develop short-term and long-term consumer strategy and roadmap for Lilly India affiliate, tailored to relevant disease areas (Obesity & T2D, Specialty, future innovative therapies)
Map current state of the Affiliate, develop scope of work, and build capabilities, systems, and processes to support consumer marketing needs for innovative therapies
Seek and apply best practices from India market and Lilly Hubs/Affiliates, adhering to regulations and compliance
Drive Disease State Education programs for relevant consumer segments and tailor content for engagement plans
Build and implement operational Patient Education plan aligned with overall market education strategy
Collaborate with cross-functional teams to align market education initiatives with business objectives
Understand critical insights and tensions among target consumer segments and patients to enhance experience and journey with strategic therapies
Devise solution strategies to address and bridge gaps in consumer/patient journey
Lead end-to-end strategy and implementation of consumer experience, including mobilizing targets for detection/diagnosis and enabling treatment adherence
Oversee excellent marketing execution of consumer marketing strategies for Lilly India’s portfolio
Drive B2B partnerships and create strategies to partner with digital health startups and ecosystem players to expand portfolio reach and bring innovative solutions

Skills

Consumer Marketing

B2B Partnerships

Marketing Strategy

Patient Experience

Digital Health

Startup Collaboration

Healthcare Ecosystem

Business Acumen

Cross-Functional Collaboration

Strategic Marketing

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free